Nephro Care India Ltd. (NEPHROCARE-SM): Nephro Care India Share Price rises 8.81% to Rs 87.05
- September 9, 2026
- Posted by: Harsh Piplani
- Category: News
Nephro Care India Share Price moved higher today, with the stock last traded at Rs 87.05, up 8.81% from the previous close of Rs 80. The company’s market capitalisation stands at Rs 131.89 crore, keeping Nephro Care India Stock News firmly on the radar in the Indian Stock Market. According to latest Univest data, the move is relevant because it is a clear same-day share price rise, even though the figures do not establish a company-specific catalyst. For investors tracking Nephro Care India Share Price Today, the key near-term lens is whether the price can hold above the opening and prior close levels while the broader Healthcare backdrop remains supportive. Univest users following Nephro Care India Share Price Live can use this move as a starting point for stock analysis rather than a standalone signal.
Nephro Care India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 87.05 |
| Previous Close | Rs 80 |
| Today's Move | Rs 7.05 (+8.81%) |
| Open | Rs 79 |
| High | Rs 87.05 |
| Low | Rs 78 |
| Turnover | Rs 0.32 crore |
| Market Capitalisation | Rs 131.89 crore |
| Market Cap Category | Micro Cap |
Nephro Care India Ltd. (NEPHROCARE-SM) rose to Rs 87.05 from the previous close of Rs 80, a move of Rs 7.05 or 8.81%. The stock opened at Rs 79, reached a high of Rs 87.05, recorded a low of Rs 78.
Nephro Care India Share Price today reflects a firm intraday move. The stock opened at Rs 79, slipped to a low of Rs 78, and then climbed to a high of Rs 87.05, which is also the last traded price. That leaves the share price rise at Rs 7.05 versus the previous close, equal to 8.81%. Turnover stood at Rs 0.32 crore, which shows there was active trading interest around the move without implying any company-specific trigger. In simple terms, Nephro Care India Stock Gaining Today is a factual description of the price action; Nephro Care India Share Price Update is driven by the move itself, not by an identified news event. For readers searching Nephro Care India Share Price News, the main takeaway is that the stock is among the day’s market movers.
Nephro Care India Ltd. (NEPHROCARE-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 131.89 crore |
| P/E Ratio | 39.15x |
| P/B Ratio | 2.26x |
| ROE | 10.62% |
| ROCE | 14.42% |
| EPS | Rs 2.04 |
| Book Value Per Share | Rs 35.46 |
| Dividend Yield | 0% |
Nephro Care India Ltd. (NEPHROCARE-SM) fundamental metrics show P/E 39.15x, P/B 2.26x, ROE 10.62%, ROCE 14.42%. These figures provide context only and are not a buy or sell signal.
Nephro Care India Ltd. has a market capitalisation of Rs 131.89 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 39.15x, P/B at 2.26x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 10.62% and ROCE of 14.42%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.04, book value per share of Rs 35.46, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 47.53x, median ROE of 13.17%, median ROCE of 15.84%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Hospital & Healthcare Services |
| Benchmark Scope | same industry |
| Company P/E Ratio | 39.15x |
| Benchmark Median P/E | 47.53x |
| Benchmark Average P/E | 100.01x |
| Benchmark P/E Range | 7.81x to 1,520.9x |
| Company P/B Ratio | 2.26x |
| Benchmark Median P/B | 4.09x |
| Company ROE | 10.62% |
| Benchmark Median ROE | 13.17% |
| Company ROCE | 14.42% |
| Benchmark Median ROCE | 15.84% |
| Company Market Capitalisation | Rs 131.89 crore |
| Benchmark Median Market Cap | Rs 547.06 crore |
Nephro Care India Ltd. (NEPHROCARE-SM) is classified under sector: Healthcare and industry: Hospital & Healthcare Services.
Nephro Care India Ltd. (NEPHROCARE-SM) has a P/E ratio of 39.15x, which is below the benchmark median of 47.53x, a difference of -17.63%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Nephro Care India Ltd. (NEPHROCARE-SM) has a ROE of 10.62%, which is below the benchmark median of 13.17%, a difference of -19.36%. Nephro Care India Ltd. (NEPHROCARE-SM) has a ROCE of 14.42%, which is below the benchmark median of 15.84%, a difference of -8.96%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP | 1,25,955.36 | 60.56 | 13.06 | 23.54 | 21.73 |
| Max Healthcare Institute Ltd. | MAXHEALTH | 96,425.85 | 66.14 | 8.82 | 14.53 | 14.97 |
| MANIPAL HEALTH ENTERPRI L | MANIPALHOS | 95,529.27 | 105.9 | 5.18 | 12.95 | 13.93 |
| Aster DM Healthcare Ltd. | ASTERDM | 69,319.75 | 216.09 | 13.86 | 9.32 | 11.46 |
| Fortis Healthcare Ltd. | FORTIS | 68,550.2 | 65.92 | 6.8 | 11.32 | 14.07 |
Nephro Care India Ltd. (NEPHROCARE-SM) has a P/E ratio of 39.15x compared with the displayed peer median of 66.14x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 10.62% compares with a peer median of 12.95% across the companies shown in the table. ROCE stood at 14.42% versus the displayed peer median of 14.07%, providing a capital-efficiency comparison. Nephro Care India Ltd. (NEPHROCARE-SM) has a market capitalisation of Rs 131.89 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Nephro Care India
- Nephro Care India Share Price rose 8.81% today, making it a notable stock in news for intraday price action.
- The stock traded between Rs 78 and Rs 87.05, with the last traded price matching the day’s high.
- Market capitalisation of Rs 131.89 crore keeps the company in the small-cap category, where price moves can be sharper.
- P/E of 39.15 and P/B of 2.26 place the stock below several same-industry benchmark levels.
- ROE of 10.62% and ROCE of 14.42% give investors a basic profitability frame for Nephro Care India Share Price analysis.
About Nephro Care India
Nephro Care India Ltd. operates in the Healthcare sector and belongs to the Hospital & Healthcare Services industry. The company’s market listing places it within a sector that is often assessed on return ratios, earnings quality and peer valuation rather than only on short-term price movement. For readers tracking Nephro Care India Company News, the stock is best understood as part of a broader hospital-services ecosystem where business performance and market valuation both matter.
At the current market cap of Rs 131.89 crore, Nephro Care India is much smaller than the leading listed healthcare names, which means its share price can react more visibly to market sentiment and liquidity shifts. The current figures show EPS of 2.04 and book value of 35.46, giving a basic financial frame for the company. Univest users searching Nephro Care India Latest News or Nephro Care India Stock Performance can therefore place today’s rise alongside scale, valuation and return metrics instead of treating it as a standalone move. For Nephro Care India Share Price readers, this broader context is useful when following the company on NSE and BSE.
Frequently Asked Questions
Why is Nephro Care India Share Price rising today?
Ans. Nephro Care India Share Price rose 8.81% today to Rs 87.05. The latest figures confirm the price event, but they do not establish a company-specific catalyst for the move.
What is Nephro Care India Share Price today?
Ans. Nephro Care India Share Price today is Rs 87.05, compared with the previous close of Rs 80. The stock gained Rs 7.05 during the move and remained in focus for intraday trading.
What is the market capitalisation of Nephro Care India?
Ans. Nephro Care India has a market capitalisation of Rs 131.89 crore. That places it in the small-cap segment and helps explain why price moves can look sharp in percentage terms.
How does Nephro Care India compare on valuation?
Ans. Nephro Care India’s P/E ratio is 39.15 and its P/B ratio is 2.26. Both sit below the same-industry median benchmark, giving the stock a comparatively moderate valuation read.
What do Nephro Care India EPS and book value show?
Ans. EPS is 2.04 and book value is 35.46. EPS shows earnings attributable per share, while book value shows the accounting value behind each share, both useful in stock analysis.
What do ROE and ROCE tell investors about Nephro Care India?
Ans. ROE is 10.62% and ROCE is 14.42%. These figures indicate the company is generating returns, though both remain below the same-industry median benchmark in this healthcare set. The relevant peer median ROE is 13.17%.
How does Nephro Care India look versus healthcare peers?
Its valuation is lower than several peers, while return ratios are mixed.
What should investors monitor in Nephro Care India Share Price?
Ans. Investors can monitor how Nephro Care India Share Price trades relative to Rs 80 and Rs 87.05, along with future company news, earnings updates and sector sentiment in Healthcare.
Track Nephro Care India Share Price on Univest
Use Nephro Care India Ltd. (NEPHROCARE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Univest helps users track Nephro Care India Share Price Live with market cap, valuation ratios, company financials, peer comparisons and sector context in one place. You can follow the stock’s latest share price, fundamental ratios, market insights and 52-week levels on Univest.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
